<?xml version="1.0" encoding="UTF-8"?>
<ref id="B24-molecules-25-00942">
 <label>24.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Basso</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Dai</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Gray</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Nale</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Tevar</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Liang</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Ponery</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Yaremko</surname>
    <given-names>B.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>SCH 2047069, a novel oral kinesin spindle protein inhibitor, shows single-agent antitumor activity and enhances the efficacy of chemotherapeutics</article-title>
  <source>Mol. Cancer Ther.</source>
  <year>2019</year>
  <volume>9</volume>
  <fpage>2993</fpage>
  <lpage>3002</lpage>
  <pub-id pub-id-type="doi">10.1158/1535-7163.MCT-10-0548</pub-id>
 </element-citation>
</ref>
